161 computer-programmer-"https:"-"FEMTO-ST" "https:" "https:" "https:" "https:" "P" "St" positions at Ulster University
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
on a programme of research leading to the award of an MRes or doctoral degree are NOT eligible to apply for funding. Applicants who hold or who are registered on a taught Master’s degree are eligible
-
hold an MRes or a doctoral degree or who have been registered on a programme of research leading to the award of an MRes or doctoral degree are NOT eligible to apply for funding. Applicants who hold or
-
roll-out across tenure types. Northern Ireland is the only part of the UK without a retrofit funding programme and this absence of financial incentivisation has created an impasse amongst homeowners
-
-invasive brain stimulation on executive functioning in healthy controls: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 125, 122-147. Hill, A. T., Fitzgerald, P. B., & Hoy, K. E
-
was established. This is a £55M programme funded by Department of Economy NI and Industry partners, managed by the UKRI Strength in Places programme. This programme is a collaboration between regional Life and
-
date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis
-
offered admission on a self-funded basis. Applicants who already hold an MRes or a doctoral degree or who have been registered on a programme of research leading to the award of an MRes or doctoral degree
-
three years preceding the start date of the research degree programme. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a
-
applicants worldwide, regardless of residency or domicile. Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a
-
for metabolic disorders such as diabetes and obesity. However, their efficacy and safety in humans remains unexplored. This PhD programme will seek to take the first critical step towards clinical translation